empty
shaddow left corner Scansol Ltd - Skin Cancer Solutions empty The UK's premier provider
of skin cancer screening services
Call 0845 604 8142
Macmillan Logo empty shaddow
shaddow   HomeAbout UsAbout Skin CancerPubluc AreaProfessionals AreaPress AreaCareersContact Us   shaddow
shaddow
BackgroundGP'sPharmacyOccupational Health
   
  Dr R Elias, Hastings & Rother NHS PBC Board
TeleDerm™ is 'a unique skin cancer tele-medicine service.
It is state of the art.'
shaddow
   
spacer
 
The Problem

In 2003, the All Party Parliamentary Group on Skin reported that 'many GPs lack the ability to diagnose suspect lesions. This has meant that a substantial number of benign lesions are being referred - 19 out of 20 in some areas'.

In 2007, the Dermatology Workforce Group recommended that “Primary care should offer patients rapid access to diagnosis of their skin disease (which) may be part of enhanced primary care service. Secondary care should do only those things that only they can do; lead and coordinate clinical and educational services and manage complex cases.”

In 2008, published research indicated that 30% of patients with melanoma were “initially diagnosed incorrectly” by GPs leading to “significant delays in treatment.”

Clearly, GPs need diagnostic support to deliver high quality skin cancer screening to their patients.

spacer
 
The Solution

In the NHS Cancer Reform Strategy 2009, National Cancer Director Professor Sir Mike Richards states;

“We need to facilitate earlier diagnosis in primary care by eliminating delays and providing GPs with better access to diagnostic tests.”

Current NICE Guidelines advise GPs that local investigations “may be necessary in respect of patients with less typical symptoms and signs that might, nevertheless, be due to cancer.”

Current NICE Guidance specifically recommends Dermoscopy - skin scoping using a special microscope - for the diagnosis of melanoma as it “yields greater diagnostic accuracy than naked eye examination.”

According to NICE Guidance, an expert Dermoscopist can achieve an unrivalled sensitivity of up to 96% and a specificity of up to 98% in the diagnosis of melanoma.


spacer
 
TeleDerm®

Scansol are the UK's experts at dermoscopy.

Our TeleDerm® service provides GPs with a 'second opinion' from GMC registered doctors - experts who hold the International Dermoscopy Diploma - confirming whether a pigmented lesion or mole is dermoscopically suspect for melanoma.

According to Dr Roger Elias, Chair of Hastings & Rother NHS Practice Based Commissioning Board;

“TeleDerm is a state of the art dermatology service, in line with NICE Guidelines. My patients have found it an excellent service. It has saved unnecessary referrals to hospital and resulted in considerable savings for the local PBC consortium.

It has been a very simple service to run and met with the approval of the vast majority of my GP colleagues. The accuracy of diagnosis has been almost 100% with no severe pathologies being misdiagnosed.”

Find out how TeleDerm® can help you. →
spacer
shaddow   Registered by the Care Quality Commission Quality Care Commision Approved by   NHS  SuperdrugBMI   shaddow
shaddow
  For The MOLE Clinic® Call 0207 734 1177. For TELEDerm® and corporate enquiries Call 0207 182 4610.
©Scansol Ltd, Company No. 04903102, Registered Office 9 Argyll Street, London W1F 7TG.
 
shaddow